Gustavo Helguera
- Biomaterials top 1%
- Hematology top 5%
- Iron Metabolism and Disorders 6
- Molecular Biology top 5%
- Glycosylation and Glycoproteins Research 3
- Genetics top 5%
- Virus-based gene therapy research 3
- Chronic Lymphocytic Leukemia Research 3
- Oncology top 10%
- HER2/EGFR in Cancer Research 4
- CAR-T cell therapy research 4
-
- Monoclonal and Polyclonal Antibodies Research 15
-
- Immunotherapy and Immune Responses 4
- Co-authors
- Manuel L. PenichetTracy R. Daniels‐WellsTracie DelgadoJosé A. RodríguezJosé Antonio RodríguezEggehard HollerJulia Y. LjubimovaMaggie Kozman
- Journals
- Molecular Cancer Therapeutics (4 papers)Clinical Immunology (3 papers)Journal of Controlled Release (2 papers)
- Partner nations
- United StatesArgentinaMexico
In The Last Decade
Gustavo Helguera
45 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Biomaterials 711
- Hematology 288
- Molecular Biology 1.4k
- Genetics 166
- Oncology 415
Countries citing papers authored by Gustavo Helguera
This map shows the geographic impact of Gustavo Helguera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gustavo Helguera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gustavo Helguera more than expected).
Fields of papers citing papers by Gustavo Helguera
This network shows the impact of papers produced by Gustavo Helguera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gustavo Helguera. The network helps show where Gustavo Helguera may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gustavo Helguera, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 3 | |
| 2 | 2018 | 67 | |
| 3 | 2018 | 10 | |
| 4 | 2018 | 8 | |
| 5 | 2016 | 37 | |
| 6 | 2015 | 2 | |
| 7 | 2014 | 41 | |
| 8 | 2013 | 35 | |
| 9 | 2011 | 12 | |
| 10 | 2011 | 25 | |
| 11 | 2009 | 43 | |
| 12 | 2008 | 35 | |
| 13 | 2008 | 34 | |
| 14 | 2007 | 27 | |
| 15 | 2006 | 24 | |
| 16 | The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancerbreakdown → | 2006 | 502 |
| 17 | 2006 | 413 | |
| 18 | 2005 | 46 | |
| 19 | 2002 | 20 | |
| 20 | 2001 | 104 |
About Gustavo Helguera
Gustavo Helguera is a scholar working on Hematology, Radiology, Nuclear Medicine and Imaging and Genetics, having authored 45 papers that have together received 2.8k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (15 papers), Iron Metabolism and Disorders (6 papers), Immunotherapy and Immune Responses (4 papers), HER2/EGFR in Cancer Research (4 papers), CAR-T cell therapy research (4 papers), Glycosylation and Glycoproteins Research (3 papers), Virus-based gene therapy research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Biomaterials (711 citations), Hematology (288 citations) and Molecular Biology (1.4k citations). Gustavo Helguera has collaborated with scholars based in United States, Argentina and Mexico. Frequent co-authors include Manuel L. Penichet, Tracy R. Daniels‐Wells, Tracie Delgado, José A. Rodríguez, José Antonio Rodríguez, Eggehard Holler, Julia Y. Ljubimova, Maggie Kozman, Shabnum Patel and Diego A. Chiappetta. Their work appears in journals such as Molecular Cancer Therapeutics, Clinical Immunology, Journal of Controlled Release, Cancer Immunology Immunotherapy and Biochimica et Biophysica Acta (BBA) - General Subjects.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.